Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
about
Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityPlacental DNA Methylation Related to Both Infant Toenail Mercury and Adverse Neurobehavioral OutcomesGenotype-based ancestral background consistently predicts efficacy and side effects across treatments in CATIE and STAR*DTowards the clinical implementation of pharmacogenetics in bipolar disorder.Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.Targeted Re-Sequencing Approach of Candidate Genes Implicates Rare Potentially Functional Variants in Tourette Syndrome EtiologyImpact of antidepressants on cytokine production of depressed patients in vitroPharmacogenetics of antidepressant drugs: an update after almost 20 years of research.Genome-wide association studies in pharmacogenomics of antidepressants.Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.Identification of EGFLAM, SPATC1L and RNASE13 as novel susceptibility loci for aortic aneurysm in Japanese individuals by exome-wide association studies.An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype.Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen.Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment.Sensorineural Hearing Loss Associated With Bupropion Use.
P2860
Q28083100-02C086BB-A9A0-43D7-B96B-F365D7D3AB7EQ28397750-C1DE6279-8641-4D9E-8058-CE073B2FB238Q28486019-2374F30A-6C86-456A-B6FF-B0CDAAA61FB5Q33688133-41A66A79-DEDE-4889-A093-FB4FD71BBD47Q35565624-AA90D959-12D1-486A-925E-8B2323A7CA41Q37270811-A09081CC-0A24-468B-A67C-0CDADE8E3F11Q37357893-F0D92F95-704A-4D58-B8D7-6CB7777898DAQ38121519-BA1E7C2B-53C0-4032-9395-250634BDD65DQ38444447-8A9A8686-9EC9-486C-AB1B-A59280AA0AEFQ38983579-241CA29B-833A-40C1-A9E1-C2E1404760C7Q40275743-1390F347-F3E9-4645-969F-95483F39E9FAQ40397660-95578646-CD87-4C52-A6A1-E74A6726E4A0Q42361493-9F554BCC-2FEE-4E34-B07F-4A1A9291987DQ47782721-1EE20DDD-8ACE-4422-9E12-F9E752830B8DQ48311592-2907876C-F3D2-4B7F-8F4F-04F7D42D09CDQ50304285-28C95ECA-484B-4EB4-9752-C08458BFDA75
P2860
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
@ast
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
@en
type
label
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
@ast
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
@en
prefLabel
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
@ast
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
@en
P2093
P2860
P356
P1476
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
@en
P2093
D E Adkins
E J C G van den Oord
J L McClay
J M Hettema
P2860
P2888
P356
10.1038/TP.2012.57
P577
2012-07-03T00:00:00Z
P5875
P6179
1022452850